Sangamo Therapeutics, Inc.
SGMO
$0.4894
$0.00631.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.18M | 41.92M | 39.20M | 27.79M | 54.42M |
| Total Receivables | 4.61M | 4.60M | 10.50M | 581.00K | 691.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.81M | 5.18M | 8.43M | 11.71M | 12.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 916.00K |
| Total Current Assets | 37.60M | 51.69M | 58.13M | 40.08M | 68.64M |
|
|
|||||
| Total Current Assets | 37.60M | 51.69M | 58.13M | 40.08M | 68.64M |
| Net Property, Plant & Equipment | 32.84M | 34.76M | 36.91M | 39.29M | 42.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.73M | 15.19M | 16.22M | 13.65M | 17.37M |
| Total Assets | 86.17M | 101.64M | 111.26M | 93.01M | 128.96M |
|
|
|||||
| Total Accounts Payable | 18.20M | 15.49M | 19.79M | 17.59M | 15.47M |
| Total Accrued Expenses | 23.80M | 17.56M | 21.99M | 16.37M | 17.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 4.31M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 7.56M | 8.45M | 1.38M | 5.05M | 7.47M |
| Total Other Current Liabilities | 7.56M | 8.45M | 1.38M | 5.05M | 7.47M |
| Total Current Liabilities | 49.56M | 45.81M | 43.16M | 39.01M | 40.24M |
|
|
|||||
| Total Current Liabilities | 49.56M | 45.81M | 43.16M | 39.01M | 40.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.88M | 26.25M | 27.73M | 29.10M | 30.82M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.82M | 6.81M | 1.24M | 1.22M | 1.21M |
| Total Liabilities | 81.26M | 78.87M | 72.13M | 69.32M | 72.26M |
|
|
|||||
| Common Stock & APIC | 1.55B | 1.53B | 1.52B | 1.52B | 1.52B |
| Retained Earnings | -1.53B | -1.50B | -1.48B | -1.49B | -1.46B |
| Treasury Stock & Other | -5.53M | -7.53M | -4.22M | -5.88M | -5.80M |
| Total Common Equity | 4.91M | 22.77M | 39.13M | 23.69M | 56.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.91M | 22.77M | 39.13M | 23.69M | 56.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.91M | 22.77M | 39.13M | 23.69M | 56.70M |
|
|
|||||